Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
J. LeLorier, M. S. Duh, P. E. Paradis, P. Lefebvre, J. Weiner, R. Manjunath, O. Sheehy
Neurology. 2008 May 27; 70(22 Pt 2): 2179–2186. doi: 10.1212/01.wnl.0000313154.55518.25

Is Cited by the Following 9 Articles in this Archive:

Mario Del Tacca, Giuseppe Pasqualetti, Giovanni Gori, Pasquale Pepe, Antonello Di Paolo, Marianna Lastella, Ferdinando De Negri, Corrado Blandizzi
Ther Clin Risk Manag. 2013; 9: 303–311. Published online 2013 July 24. doi: 10.2147/TCRM.S39024
PMCID:
PMC3726593
Daniel M. Hartung, Luke Middleton, Leanne Svoboda, Jessina C. McGregor
CNS Drugs.
Published in final edited form as: CNS Drugs. 2012 August 1; 26(8): 707–716. doi: 10.2165/11634260-000000000-00000
PMCID:
PMC3677951
Petros Pechlivanoglou, Willem Jan van der Veen, Jens H Bos, Maarten J Postma
BMC Health Serv Res. 2011; 11: 89. Published online 2011 April 27. doi: 10.1186/1472-6963-11-89
PMCID:
PMC3107776
Susan J. Shaw, Adam L. Hartman
J Pediatr Pharmacol Ther. 2010 Apr-Jun; 15(2): 81–93.
PMCID:
PMC3018179
Stephanie J. Phelps
J Pediatr Pharmacol Ther. 2010 Apr-Jun; 15(2): 66–67.
PMCID:
PMC3018182
Aaron S. Kesselheim, Margaret R. Stedman, Ellen J. Bubrick, Joshua J. Gagne, Alexander S. Misono, Joy L. Lee, M. Alan Brookhart, Jerry Avorn, William H. Shrank
Drugs.
Published in final edited form as: Drugs. 2010 March 26; 70(5): 605–621. doi: 10.2165/10898530-000000000-00000
PMCID:
PMC3056509
Bernhard J Steinhoff, Uwe Runge, Otto W Witte, Hermann Stefan, Andreas Hufnagel, Thomas Mayer, Günter Krämer
Ther Clin Risk Manag. 2009; 5: 449–457. Published online 2009 June 22.
PMCID:
PMC2701486
Dalia Buffery
Am Health Drug Benefits. 2008 September; 1(7): 18–19.
PMCID:
PMC4106570